Skip to main content
. 2022 Oct 1;128(22):3943–3950. doi: 10.1002/cncr.34473

TABLE 1.

Clinical characteristics of enrolled patients with extranodal NK/T‐cell lymphoma, nasal‐type (n = 742)

Primary cohort Validation cohort
Characteristics No. (%) No. (%)
All 186 556
Sex
Male 140 (75.3) 391 (70.3)
Female 46 (24.7) 165 (29.7)
Age, y
≤60 153 (82.3) 472 (84.9)
>60 33 (17.7) 84 (15.1)
Primary site
UADT 143 (76.9) 489 (87.9)
Extra‐UADT 43 (23.1) 67 (12.1)
Regional lymph nodes
Yes 73 (39.2) 271 (48.7)
No 113 (60.8) 285 (51.3)
Distant lymph nodes
Yes 51 (27.4) 52 (9.4)
No 135 (72.6) 504 (90.6)
B symptoms
Yes 120 (64.5) 186 (33.5)
No 66 (35.5) 370 (66.5)
Elevated LDH
Yes 101 (54.3) 187 (33.6)
No 85 (45.7) 369 (66.4)
ECOG score
0‐1 140 (75.3) 548 (98.5)
≥2 46 (24.7) 8 (1.5)
Ann Arbor stage
I‐II 100 (53.8) 423 (76.1)
III‐IV 86 (46.2) 133 (23.9)
Bone marrow aspiration
Negative 156 (83.9) 547 (98.4)
Positive 30 (16.1) 9 (1.6)
Bone marrow biopsy
Negative 141 (75.8) 534 (96.0)
Positive 45 (24.2) 22 (4.0)
PET/CT
Yes 139 (74.7) 425 (76.4)
No 47 (25.3) 131 (23.6)

Abbreviations: CT, computed tomography; ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; PET, positron emission tomography; UADT, upper aerodigestive tract.